Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.
Funder: American Association for Cancer Research
Due Dates (Anticipated): March 2027 (Full application submission deadline, projected)
Funding Amounts: $50,000 for a 1-year project; no indirect costs allowed; funds may support PI, personnel, supplies, equipment, and limited travel.
Summary: Supports innovative basic, translational, or clinical research identifying new targets or biomarkers relevant to kidney cancer.
Key Information: Applicants must be independent investigators with a doctoral degree and AACR Active membership.
This grant aims to stimulate creative research approaches that translate basic science into new treatment options for kidney cancer. It supports basic, translational, and clinical projects focused on identifying and investigating important and druggable novel targets and/or biomarkers relevant to kidney cancer. The program encourages applications from both established kidney cancer researchers and investigators from other biomedical fields with promising ideas that can be applied to kidney cancer research.